Woodline Partners’s Upstream Bio Inc UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.75M Hold
831,481
0.02% 657
2026
Q1
$7.48M Buy
831,481
+71,229
+9% +$1.28M 0.03% 579
2025
Q4
$20.6M Buy
760,252
+158,000
+26% +$3.93M 0.08% 305
2025
Q3
$11.3M Buy
602,252
+44,000
+8% +$684K 0.05% 415
2025
Q2
$6.13M Buy
558,252
+1,189
+0.2% +$11K 0.03% 523
2025
Q1
$3.41M Buy
557,063
+30,552
+6% +$292K 0.02% 589
2024
Q4
$8.66M Buy
+526,511
New +$11.8M 0.06% 379

Other funds holding UPB

Woodline Partners's UPB Position: Q2 2026 in Review

Woodline Partners held its Upstream Bio Inc (UPB) position steady in Q2 2026 at 831,481 shares worth $5.75M. The position accounts for 0.02% of the portfolio, ranked #657.

Woodline Partners first reported a position in UPB in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.6M in Q4 2025. 148 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Woodline Partners held 831,481 shares of Upstream Bio Inc worth $5.75M as of Q2 2026.
  • Woodline Partners left its Upstream Bio Inc share count unchanged in Q2 2026.
  • Upstream Bio Inc made up 0.02% of Woodline Partners's portfolio in Q2 2026, its #657 holding.
  • Woodline Partners first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 7 quarters since.
  • Woodline Partners's Upstream Bio Inc position peaked at $20.6M in Q4 2025.
  • 148 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.